CareDx Shares Outstanding 2013-2025 | CDNA
CareDx shares outstanding from 2013 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
|
CareDx Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 57 |
| 2023 | 54 |
| 2022 | 53 |
| 2021 | 52 |
| 2020 | 46 |
| 2019 | 42 |
| 2018 | 36 |
| 2017 | 23 |
| 2016 | 16 |
| 2015 | 12 |
| 2014 | 9 |
| 2013 | 1 |
| 2012 | 1 |
|
CareDx Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-09-30 | 54 |
| 2025-06-30 | 54 |
| 2025-03-31 | 55 |
| 2024-12-31 | 57 |
| 2024-09-30 | 53 |
| 2024-06-30 | 52 |
| 2024-03-31 | 52 |
| 2023-12-31 | 54 |
| 2023-09-30 | 54 |
| 2023-06-30 | 54 |
| 2023-03-31 | 54 |
| 2022-12-31 | 53 |
| 2022-09-30 | 53 |
| 2022-06-30 | 53 |
| 2022-03-31 | 53 |
| 2021-12-31 | 52 |
| 2021-09-30 | 53 |
| 2021-06-30 | 52 |
| 2021-03-31 | 51 |
| 2020-12-31 | 46 |
| 2020-09-30 | 49 |
| 2020-06-30 | 45 |
| 2020-03-31 | 43 |
| 2019-12-31 | 42 |
| 2019-09-30 | 42 |
| 2019-06-30 | 42 |
| 2019-03-31 | 42 |
| 2018-12-31 | 36 |
| 2018-09-30 | 37 |
| 2018-06-30 | 36 |
| 2018-03-31 | 30 |
| 2017-12-31 | 23 |
| 2017-09-30 | 23 |
| 2017-06-30 | 21 |
| 2017-03-31 | 21 |
| 2016-12-31 | 16 |
| 2016-09-30 | 19 |
| 2016-06-30 | 14 |
| 2016-03-31 | 12 |
| 2015-12-31 | 12 |
| 2015-09-30 | 12 |
| 2015-06-30 | 12 |
| 2015-03-31 | 12 |
| 2014-12-31 | 9 |
| 2014-09-30 | 11 |
| 2014-06-30 | 7 |
| 2014-03-31 | 1 |
| 2013-12-31 | 1 |
| 2013-09-30 | 1 |
| 2013-06-30 | 1 |
| 2013-03-31 | 1 |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.010B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.156B | 27.25 |
| HCA Healthcare (HCA) | United States | $120.821B | 19.12 |
| CVS Health (CVS) | United States | $99.843B | 11.63 |
| Elevance Health (ELV) | United States | $76.540B | 11.49 |
| Cencora (COR) | United States | $69.998B | 22.08 |
| Natera (NTRA) | United States | $28.526B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.430B | 17.87 |
| DiDi Global (DIDIY) | China | $21.650B | 20.00 |
| Viatris (VTRS) | United States | $18.163B | 6.77 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.306B | 0.00 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Solventum (SOLV) | United States | $13.104B | 12.72 |
| Medpace Holdings (MEDP) | United States | $12.148B | 27.98 |
| Revvity (RVTY) | United States | $10.888B | 18.94 |
| CochLear (CHEOY) | Australia | $9.243B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.941B | 15.29 |
| ICON (ICLR) | Ireland | $7.510B | 7.45 |
| Sonic Healthcare (SKHHY) | Australia | $7.449B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.008B | 41.78 |
| HealthEquity (HQY) | United States | $6.312B | 23.60 |
| Avantor (AVTR) | United States | $6.275B | 10.11 |
| Bausch + Lomb (BLCO) | Canada | $6.034B | 39.60 |
| PACS (PACS) | United States | $5.922B | 36.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.818B | 0.00 |
| Sotera Health (SHC) | United States | $4.864B | 23.45 |
| Alignment Healthcare (ALHC) | United States | $4.040B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.017B | 18.83 |
| GeneDx Holdings (WGS) | United States | $2.606B | 45.76 |
| Establishment Labs Holdings (ESTA) | United States | $2.168B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.000B | 25.77 |
| Organon (OGN) | United States | $1.921B | 2.15 |
| Pediatrix Medical (MD) | United States | $1.848B | 11.04 |
| Progyny (PGNY) | United States | $1.784B | 35.07 |
| Ardent Health (ARDT) | United States | $1.375B | 4.49 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| Teladoc Health (TDOC) | United States | $0.825B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.740B | 12.11 |
| Nutex Health (NUTX) | United States | $0.705B | 5.39 |
| Omada Health (OMDA) | United States | $0.655B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.641B | 0.00 |
| Embecta (EMBC) | United States | $0.602B | 3.36 |
| Enhabit (EHAB) | United States | $0.565B | 25.36 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.558B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.478B | 8.79 |
| CryoPort (CYRX) | United States | $0.418B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.396B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.367B | 5.90 |
| So-Young (SY) | China | $0.328B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.247B | 0.00 |
| Agilon Health (AGL) | United States | $0.150B | 0.00 |
| LifeMD (LFMD) | United States | $0.134B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.078B | 0.00 |
| DocGo (DCGO) | United States | $0.073B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.018B | 5.62 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |